TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06450431

Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.

Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.

Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.

Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.

Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.
Study: NCT06412328

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: The psychoeducation program based on psychosocial support is a total of 8 sessions. Families participating in the study received the psychoeducation program over 4 weeks, with two sessions per week, each session lasting 60 minutes. Parents were included in group work during the psychoeducation program.
Study: NCT05158556

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Technique
Description: Myofascial Release Technique will be applied with forearm/ ulnar border of palm. Deep pressure will be applied and glided medially towards the thoraco-lumbar region.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Technique
Description: Myofascial Release Technique will be applied with forearm/ ulnar border of palm. Deep pressure will be applied and glided medially towards the thoraco-lumbar region.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument Assisted Soft tissue Mobilization
Description: instrument assisted soft tissue mobilization is done via M2T Blade. it is a multifunctional instrument consisting of many planes and is very effective in treating pain and spasm. Its efficacy is proven over soft tissues that it releases fascial tightness.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument Assisted Soft tissue Mobilization
Description: instrument assisted soft tissue mobilization is done via M2T Blade. it is a multifunctional instrument consisting of many planes and is very effective in treating pain and spasm. Its efficacy is proven over soft tissues that it releases fascial tightness.
Study: NCT05312788

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Description: Intervention will involve intake of 50% barley substituted wheat bread.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Description: Intervention will involve intake of 50% barley substituted wheat bread.
Study: NCT05355233

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bebo concept
Description: techniques to remove urinary incontinence

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: diaphragmatic breathing
Description: techniques to remove urinary incontinence
Study: NCT04868539

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Artificial Light At Night
Description: 90 lux lighting for 19hr/day

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction
Description: 5-hr of sleep/night

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction
Description: 5-hr of sleep/night
Study: NCT05141214

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Application
Description: In VR application, Chaos Café, patients are immersed into a computer-generated kitchen environment. A humorous robotic chef serves children different food groups. Gameplay is advanced by choosing healthy foods, while eating unhealthy foods does not advance the application.
Study: NCT05252156

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eXciteOSA
Description: eXciteOSA

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eXciteOSA
Description: eXciteOSA
Study: NCT04923841

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and single vision spectacle lenses
Description: High intensity light box for bright light therapy and single vision spectacle lenses

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses
Description: High intensity light box for bright light therapy and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and atropine 0.01% eye drop and and single vision spectacle lenses
Description: High intensity light box for bright light therapy and atropine 0.01% eye drop and and single vision spectacle lenses

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Atropine 0.01% eye drop and and single vision spectacle lenses
Description: Atropine 0.01% eye drop and and single vision spectacle lenses
Study: NCT05073237

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily placebo tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: conjugated estrogens/bazedoxifene (CE/BZA)
Description: Participants assigned to CE/BZA will receive a daily tablet containing conjugated estrogens 0.45 mg and bazedoxifene 20mg.
Study: NCT04911556

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum
Description: types of intestinal flora

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum
Description: types of intestinal flora

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum
Description: types of intestinal flora

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: A placebo made of starch
Description: placebo
Study: NCT04771611

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisetin
Description: \~20mg/kg /day oral for four days (days 0,1 and days 8,9)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Looks exactly like the study drug, but it contains no active ingredient . Oral for four days (days 0,1 and days 8,9)
Study: NCT05567783

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-2482 (450 mg)
Description: VIR-2482 450mg given by intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-2482 (1200 mg)
Description: VIR-2482 1200 mg given by intramuscular injection

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sterile 0.9% (w/v) sodium chloride solution given by intramuscular injection
Study: NCT05670301

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: cytokine and lipidomic profiling
Description: * FEBRIS Cytokine Profile Assay (quantification of inflammatory cytokines)~* Serum amyloid A~* Biobanking of leftover sample for future analyses and specific immunofunctional assay in selected cases~* Lipidomics
Study: NCT05827211

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antibiotic group
Description: Partially or fully edentulous smoker patients will be treated by dental implants and will receive systemic antibiotics

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Non-Antibiotic group
Description: Partially or fully edentulous smoker patients will be treated by dental implants and will receive placebo
Study: NCT05519397

Intervention type: DIAGNOSTIC_TEST
Intervention: Immune checkpoint measurement
Description: Measurement of sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-β1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9

Intervention type: DIAGNOSTIC_TEST
Intervention: Immune checkpoint measurement
Description: Measurement of sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-β1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9

Intervention type: DIAGNOSTIC_TEST
Intervention: Immune checkpoint measurement
Description: Measurement of sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-β1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9
Study: NCT06494917

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor exercises
Description: First arm; Pelvic Floor Exercises (PFE) consisting of diaphragm breathing training, bridge exercise to strengthen the pelvic floor, 3-dimensional diaphragm exercise, 'I Love you massage' for intestinal motility, happy baby pose, child position exercise, full squat, adductor and iliopsoas stretching, mermaid position exercise, 'Shhh' sound exercise, 'Üüüü' sound exercise will be applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor exercises and manual therapy techniques
Description: Second arm; Pelvic Floor Exercises (PFE) consisting of diaphragm breathing training, bridge exercise to strengthen the pelvic floor, 3-dimensional diaphragm exercise, 'I Love you massage' for intestinal motility, happy baby pose, child position exercise, full squat, adductor and iliopsoas stretching, mermaid position exercise, 'Shhh' sound exercise, 'Üüüü' sound exercise will be applied. In addition to diaphragmatic breathing training and pelvic floor exercises, manual therapy methods such as momentum minus mobilisation, sphincter opening, colon massage, global fascia manipulation, trigger point and myofascial release will be applied.
Study: NCT05128721

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Covi Vax
Description: Inactivated SARS-COV-2 Vaccine/alum adjuvant preparation in addition to excipients (NRC-VACC- 101) administered as an IM Injection. NRC-VACC-101 is provided as a single dose of inactivated vaccine of opaque white liquid free from visible particles filled in injection vial (2R) glass vials. Each Dose of Covi Vax Vaccine contains 6 mcg antigen of A human coronavirus (hCoV)-19/Egypt/NRC-03/2020 SARS-CoV-2 strain.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Covi Vax
Description: Inactivated SARS-COV-2 Vaccine/alum adjuvant preparation in addition to excipients (NRC-VACC- 101) administered as an IM Injection. NRC-VACC-101 is provided as a single dose of inactivated vaccine of opaque white liquid free from visible particles filled in injection vial (2R) glass vials. Each Dose of Covi Vax Vaccine contains 6 mcg antigen of A human coronavirus (hCoV)-19/Egypt/NRC-03/2020 SARS-CoV-2 strain.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Covi Vax
Description: Inactivated SARS-COV-2 Vaccine/alum adjuvant preparation in addition to excipients (NRC-VACC- 101) administered as an IM Injection. NRC-VACC-101 is provided as a single dose of inactivated vaccine of opaque white liquid free from visible particles filled in injection vial (2R) glass vials. Each Dose of Covi Vax Vaccine contains 6 mcg antigen of A human coronavirus (hCoV)-19/Egypt/NRC-03/2020 SARS-CoV-2 strain.
Study: NCT06351306

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thioguanine (Tabloid ®)
Description: 60-80mg/m\^2 oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DecitabineCedazuridine (Inqovi ®)
Description: 35 mg decitabine and 100 mg cedazuridine oral tablet
Study: NCT05090553

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Spinal Fusion Surgery
Description: During surgery will be collected five disc fragments and five fragments of muscle-ligament tissue adjacent to the collected disc.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacterial culture
Description: Samples will be seeded on blood agar and anaerobic blood agar plates. After sowing in solid media, the swab will be inoculated in thioglycolate medium, where it will remain for 14 days

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Phenotypic and genotypic characterization
Description: The phenotypic identification of the species will be carried out through mass spectrometry, with the MALDI-TOF equipment.~PCR analyzes performed in two phases, the first to confirm the presence of bacteria (target and non-target) using primers capable of amplifying eubacteria ribosomal deoxyribonucleic acid (rDNA) 16s and the second directed to confirm C. acnes through specific rDNA 16s primers.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Multiomics analysis
Description: Whole Genome Sequencing, proteomics and metabolomics analysis
Study: NCT04942093

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: With low-calorie, high-protein diet
Description: A low-calorie, high-protein diet will be prescribed to the patient for a period of 4 weeks. The diet will be done the 4 weeks before the bariatric surgery

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Without low-calorie, high-protein diet
Description: A low-calorie, high-protein diet will not be prescribed to the patient for a period of 4 weeks.
Study: NCT05928130

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plyometric training protocol
Description: The plyometric training program will last for 4 weeks, with three sessions per week. The plyometric exercises will be performed immediately after a warm-up. The program will incorporate bilateral, unilateral, acyclic, cyclic, horizontal, vertical, lateral, and diagonal movements involving both slow and fast movements.~Each session will include 4-5 plyometric exercises, with 2-10 sets per exercise and 1-10 repetitions per set. The training volume will progressively increase from the 1st to the 2nd week and then the intensity will increase while the volume decreases from the 3rd to the 4th week in both intervention groups. However, the final volume will vary by 50% between the groups.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plyometric training protocol
Description: The plyometric training program will last for 4 weeks, with three sessions per week. The plyometric exercises will be performed immediately after a warm-up. The program will incorporate bilateral, unilateral, acyclic, cyclic, horizontal, vertical, lateral, and diagonal movements involving both slow and fast movements.~Each session will include 4-5 plyometric exercises, with 2-10 sets per exercise and 1-10 repetitions per set. The training volume will progressively increase from the 1st to the 2nd week and then the intensity will increase while the volume decreases from the 3rd to the 4th week in both intervention groups. However, the final volume will vary by 50% between the groups.
Study: NCT05029960

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brivaracetam
Description: Dose of 50 mg twice daily for 6 months
Study: NCT05286697

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: measuring optic nerve diameter
Description: During the measurement of the optic nerve diameter, a layer of sterile water-soluble gel will be applied on the closed eyelid with a linear 10-5 MHz ultrasound probe.
Study: NCT06528639

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT
Description: Three times a week, 10 sets each session, for 24 weeks of high-intensity interval training.
Study: NCT04768257

Intervention type: BEHAVIORAL
Intervention: Physical activity
Description: We will assess physical activity patterns of patients at baseline (at discharge from hospital or at patients' home), at 12 weeks and 6 months, through an objective measurement (triaxial accelerometer).

Intervention type: BEHAVIORAL
Intervention: Physical activity
Description: We will assess physical activity patterns of patients at baseline (at discharge from hospital or at patients' home), at 12 weeks and 6 months, through an objective measurement (triaxial accelerometer).

Intervention type: BEHAVIORAL
Intervention: Physical activity
Description: We will assess physical activity patterns of patients at baseline (at discharge from hospital or at patients' home), at 12 weeks and 6 months, through an objective measurement (triaxial accelerometer).
Study: NCT06441084

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NCR300 injection
Description: Subjects will receive at least 1 cycle of NCR300 injection.
Study: NCT05737290

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Clear aligners
Description: Patients with mild anterior crowding will be treated with non-extraction treatment using clear aligners.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fixed appliances
Description: Patients with mild anterior crowding will be treated with non-extraction treatment using fixed appliances.
Study: NCT03920709

Intervention type: OTHER
Intervention: Blood sample and Nasal swabs (right an left) samples
Description: Nasal swabs (right and left) will be performed (FLOQSwabTM)~Blood samples of 20 mL EDTA will be taken in addition to the current care report

Intervention type: OTHER
Intervention: Blood sample and Nasal swabs (right an left) samples
Description: Nasal swabs (right and left) will be performed (FLOQSwabTM)~Blood samples of 20 mL EDTA will be taken in addition to the current care report

Intervention type: OTHER
Intervention: Blood sample and Nasal swabs (right an left) samples
Description: Nasal swabs (right and left) will be performed (FLOQSwabTM)~Blood samples of 20 mL EDTA will be taken in addition to the current care report
Study: NCT04777253

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback method
Description: Patients in the study group will participate in training with visual biofeedback, aimed to improve motor function of the arm. The exercise will be performed using a Biometrics device. The biofeedback training will be carried out for 30 minutes per day.~Health-resort based rehabilitation The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health-resort based rehabilitation
Description: The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy

Intervention type: OTHER
Group type: OTHER
Intervention: Health-resort based rehabilitation
Description: The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy
Study: NCT05620251

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Assessment of humoral immune response

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Assessment of humoral immune response
Study: NCT04709822

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visuospatial Interference
Description: Two remote intervention sessions with a researcher including a simple cognitive task (a memory cue and 25 minutes of Tetris game play with mental rotation) alongside accompanying information.~Participants are instructed that they may continue using the technique self-guided after the first intervention session, and they may opt for additional intervention sessions with remote researcher support (maximum 6 intervention sessions).
Study: NCT05518864

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IALURIL Prefill
Description: GAG therapy (bladder instillations with glycosaminoglycans)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IALURIL Prefill
Description: GAG therapy (bladder instillations with glycosaminoglycans)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IALURIL Prefill
Description: GAG therapy (bladder instillations with glycosaminoglycans)
Study: NCT05015946

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Small-sided team handball training
Description: 60 minutes small-sided team handball training. Initial 20 minutes of warm-up including exercises for strength, aerobic, balance, coordination, and mobility. Hereafter 20 minutes of handball specific exercises including dribbling, running and shooting. Final 20 minutes of small-sided handball matches.
Study: NCT06287723

Intervention type: BIOLOGICAL
Intervention: Blood sample/Liquid biopsy
Description: ctDNA analysis
Study: NCT06109571

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Connections App
Description: The Connections app was developed for patients with substance use disorders or unhealthy substance use and adapted to include HIV support. For this study, it has been modified to provide additional resources to support patients engaged in HIV care. Connections' core features include agency-specific informational resources compiled in a resource center, patient self-monitoring through weekly check-in surveys, discussion rooms, and private messaging.